Zenith

  • Latest News

    Saturday, December 12, 2020

    Pfizer, Biontech Vaccine Could Rollout in U.S. Next Week

    The United States will likely begin from Monday, mass vaccination of its people against COVID-19, following FDA approval for the use of Pfizer-BioNTech vaccine on Friday night.

    The approval of the vaccine marked a turning point in a country where the pandemic has killed more than 295,000 people and infected over 15 million.

    The U.S. Food and Drug Administration granted an emergency use authorization for the vaccine, developed with German partner BioNTech, which was shown to be 95% effective in preventing the disease in a late-stage trial.

    It said the vaccine can be given to people aged 16 and older.

    Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of a first round of 2.9 million doses this month.

    BioNTech Chief Executive Ugur Sahin said the vaccine “will help to save lives across the United States and could accelerate a return to normality.”

    U.S. health authorities, shipping services, hospitals and pharmacies have been readying a nationwide inoculation campaign.

    • Blogger Comments
    • Facebook Comments

    0 comments:

    Item Reviewed: Pfizer, Biontech Vaccine Could Rollout in U.S. Next Week Rating: 5 Reviewed By: BrandIconImage
    Scroll to Top